A multi-centre, randomised, double-blind, placebo-controlled dose finding study in 4 parallel groups to establish the efficacy and safety of an eight week treatment with itopride three times daily compared to placebo in patients suffering from functional dyspepsia
Phase of Trial: Phase II/III
Latest Information Update: 26 Mar 2007
At a glance
- Drugs Itopride (Primary)
- Indications Non-ulcer dyspepsia
- Focus Therapeutic Use
- 26 Mar 2007 New trial record.